The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Bone Disease and HIV Infection
Abstract
The high prevalence of bone demineralization among human immunodeficiency virus (HIV)-infected patients in the current therapeutic era has been described in multiple studies, sounding the alarm that we may expect an epidemic of fragility fractures in the future. However, despite noting high overall prevalences of osteopenia and osteoporosis, recent longitudinal studies that we review here have generally not observed accelerated bone loss during antiretroviral therapy beyond the initial period after treatment initiation. We discuss the continued progress toward understanding the mechanisms of HIV-associated bone loss, particularly the effects of HIV infection, antiretroviral therapy, and host immune factors on bone turnover. We summarize results of clinical trials published in the past year that studied the safety and efficacy of treatment of bone loss in HIV-infected patients and provide provisional opinions about who should be considered for bone disease screening and treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bone density at various sites for prediction of hip fractures
Cummings, S. R., Browner, W., Cummings, S. R., Black, D. M., Nevitt, M. C., Browner, W., Genant, H. K., Cauley, J., Ensrud, K., Scott, J., et al. (1993) · The Lancet · doi:10.1016/0140-6736(93)92555-8 · Cited by 2,446 · cited 1×
“On the basis of results of large epidemiologic studies that clearly correlated the risk of decreased bone mineral density (BMD; as measured by dual X-ray absorptiometry [DEXA]) with an increased incidence of fragility fracture [15], a World Health Organization committee provided definitions of osteoporosis and osteope…”
Gallant, J. E. (2004) · JAMA · doi:10.1001/jama.292.2.191 · Cited by 1,341 · cited 2×
“Recently, the contribution of HIV infection to bone demineralization has been clarified further, with publication of the baseline BMD data from Gilead Study 903 [27].”
Updated Data on Proximal Femur Bone Mineral Levels of US Adults
Looker, A. C., Wahner, H. W., Dunn, W. L., Calvo, M. S., Harris, T. B., Heyse, S. P., Johnston Jr, C. C., & Lindsay, R. (1998) · Osteoporosis International · doi:10.1007/s001980050093 · Cited by 1,121 · cited 1×
“The investigators found a baseline prevalence of osteopenia of 23% in the tenofovir group and 28% in the stavudine group (mean age of subjects, 36 years) [28], which is significantly higher than the national prevalence among US adults [29].”
BackgroundPre-Existing Fractures and Bone Mass Predict Vertebral Fracture Incidence in Women
Ross, P. D., Davis, J. W., Epstein, R. S., & Wasnich, R. D. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-11-919 · Cited by 1,107
Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy
Tebas, P., Powderly, W. G., Claxton, S., Marin, D., Tantisiriwat, W., Teitelbaum, S. L., & Yarasheski, K. E. (2000) · AIDS · doi:10.1097/00002030-200003100-00005 · Cited by 532
Self-citationDecreased bone mineral density in HIV-infected patients is independent of antiretroviral therapy
Bruera, D., Luna, N., David, D. O., Bergoglio, L. M., & Zamudio, J. (2003) · AIDS · doi:10.1097/00002030-200309050-00010 · Cited by 240
BMD Is Reduced in HIV-Infected Men Irrespective of Treatment
Amiel, C., Ostertag, A., Slama, L., Baudoin, C., N'Guyen, T., Lajeunie, E., Neit-Ngeilh, L., Rozenbaum, W., & De Vernejoul, M. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.0301246 · Cited by 150 · cited 2×
“The high prevalence of bone demineralization among HIV-infected patients has been described in multiple studies [1-12], although longitudinal studies have not generally observed accelerated bone loss beyond the initial period after ART initiation.”
Background
Cited by
Immune activation and inflammation in HIV‐1 infection: causes and consequences
Appay, V, & Sauce, D. (2008) · The Journal of Pathology · doi:10.1002/path.2276 · Cited by 743
Weitzmann, M. N. (2013) · Scientifica · doi:10.1155/2013/125705 · Cited by 259
Ofotokun, I., Titanji, K., Lahiri, C. D., Vunnava, A., Foster, A., Sanford, S. E., Sheth, A. N., Lennox, J. L., Knezevic, A., Ward, L., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw331 · Cited by 50
Bone mineral density in young women on methadone substitution
Milos, G., Gallo, L. M., Sosic, B., Uebelhart, D., Goerres, G., Haeuselmann, H.-J., & Eich, D. (2011) · Calcified Tissue International · doi:10.1007/s00223-011-9510-4 · Cited by 18
The effect of opioid dependence on conventional and novel biochemical parameters of bone metabolism
Balodimos, S., Nikolaou, K., Njau, S., Karamouzis, M., & Kovatsi, L. (2015) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952990.2015.1068321 · Cited by 9
Metadata
- Authors
- Mayer, K. H., Amorosa, V., & Tebas, P.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-01-01
- Volume
- 42
- Issue
- 1
- Pages
- 108-114
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2172226708
- Cited by
- 158
- References
- 7
- FWCI
- 14.27
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Bone Disease and HIV Infection. https://app.cochat.ai/papers/10.1086/498511
- The paper
- Mayer, K. H., Amorosa, V., & Tebas, P. (2006). Bone Disease and HIV Infection. Clinical Infectious Diseases. https://doi.org/10.1086/498511
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.